ArticleVaccines2024

Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies.

Kegomoditswe Malebo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.